Long-term and low-grade safety results of a phase III study (PARAMOUNT): maintenance Pemetrexed plus best supportive care versus placebo plus best supportive care immediately after induction treatment with Pemetrexed plus Cisplatin for advanced nonsquamous non-small-cell lung cancer - Pujol, Jean-Louis; Thomas, Michael (Clinical lung cancer, 2014)
Gesehen am 13.11.2015